Metastatic Breast Cancer Preceptorship

International Women’s Month
Hotel Crown Plaza | Rohini, Delhi Feb 2 - Feb 3, 2019 Past


Metastatic Breast Cancer Preceptorship

2-3 February 2019 | Hotel Crown Plaza | Rohini, New Delhi



Overview and Objectives

The Metastatic Breast Cancer Preceptorship is a comprehensive programme for Indian practitioners that include scientific presentations, interactive case studies and discussions. This meeting is designed to allow clinicians and young oncologists to stay up-to-date and assimilate new information into daily clinical practice. Spearheaded by an esteemed faculty, the programme provides a platform for clinicians to:

  • Discuss contemporary clinical data on targeted therapies in mBC
  • Discuss the value of CDK4/6 inhibitors & their role in transforming the current & future standard of care for Hormone receptor positive & Her2Neu negative metastatic breast cancer
  • Understand how patient outcomes along the treatment continuum can be optimized
  • Share experience and best practices on the real-world use of targeted therapies in mBC

Program Director:Dr D. C. Doval (+91-11-47022252)

Program Coordinator: Dr Chaturbhuj Agrawal (+91-9810354544)

Logistics Coordinator: Mr. Purushottam (+91-9873608440)

Logistics Coordinator: Mr. Manoj Chauhan (+91-9873722247) 


Day 1 : 2nd February, 2019
S. No. Time Session Topic Speaker / Facilitator
1 17:00-17:20 Registration
2 17:20-17:30 Welcome and opening remarks Dr. D. C. Doval
3 17:30-17:50 The evolving treatment landscape of mBC: The past, present and future Dr. Vineet Talwar
4 17:50-18:10 Research translation into clinic: Targetable pathways in mBC Dr. Peush Bajpai
5 18:10-18:30 Tea break
6 18:30-19:30 Meet the multidisciplinary mBC team at RGCI: How we work together

    • Interactive session with the panel
    • 10 mins presentation each on their role in the team and how they work together to contribute to mBC patient care
    • Question and answer with discussion at the end

Facilitator : Dr. Chaturbhuj Agrawal

Multidisciplinary mBC team
Dr. Avinash Rao
Dr. Anurag Mehta
Dr. Rajeev Kumar
Dr. Kumardeep Dutta
Dr. Kundan Chufal
Dr. Harsha Agarwal
7 19:30-19:45 Ongoing research in the field of breast cancer: RGCI Dr. D. C. Doval
8 19:45-20:00 Summary of the day and close Dr. D. C. Doval
9 20:00 – onwards Dinner
Day 2 : 3rd February, 2019
S. No. Time Session topic Speaker / Facilitator
Perspectives in HR+ HER2- mBC
1 9:00-9:10 Opening remarks Dr. D. C. Doval
2 9:10-9:30 CDK 4/6 inhibitors in breast cancer: what the existing trials revealed? Dr. Kumardeep Dutta
3 9:30-9:45 Global real world evidence with Palbociclib: Is it really practice changing? Dr. Meenu Walia
4 9:45-10:00 Real world evidence with Palbociclib: Experience in Indian patients Dr. Chaturbhuj Agrawal
5 10:00-10:20 CDK 4/6 inhibitors in breast cancer: what the future looks like Dr. Chandragouda D.
6 10:20-10:40 Optimal sequencing of available treatment options in the HR+/Her2Neu negative mBC Dr. P. Suresh
7 10:40-11:00 Panel discussion:The CDK4/6 inhibitors conundrum: How do I choose and which should I use?

Moderator: Dr. Ullas Batra

Dr. Meenu Walia
Dr. Chandragouda D.
Dr. Kumardeep Dutta
Dr. P. Suresh
Dr. Rajat Bajaj
Dr. Samit Purohit
8 11:00-11:20 Tea break
9 11:20-12:30 Experience across different mBC patient population: Case Discussion

Presentation 1: Case: HR+/HER2- MBC (Postmenopausal female) Dr. Varun Goel
Presentation 2: Case: HR+/HER2- MBC (Premenopausal female) Dr. Manish Sharma
Presentation 3: Case: TNBC – MBC Dr. Parveen Jain
Presentation 4: Case: HER2Neu+ HR- MBC Dr Rajat Bajaj
Perspectives in metastatic TNBC and HER2+ mBC
10 12:30-12:50 The role of Molecular Testing in breast cancer: How far we come? Dr. Moushami Suryavanshi
11 12:50-13:10 Optimizing outcomes in HER2+ mBC: Emerging evidence and practice strategies Dr. Sameer Khatri
12 13:10-13:25 What progress have we made in metastatic TNBC? Dr. Sumit Goyal
13 13:25-13:45 Panel discussion : The changing face of TNBC and HER2+ metastatic breast cancer
Moderator: Dr. Randeep Singh
Dr. Sumit Goyal
Dr. Pankaj Goyal
Dr. Varun Goel
Dr. Mansi Sharma
Dr. A. P. Dubey
Dr. Abhishek Yadav
14 13:45-14:00 Summary and Close Dr. D. C. Doval
15 14:00-Onwards Lunch and Departure



Opportunity to Help


As a society, RGCIRC is looking forward to get support from generous people

Read More

It is a fact that there are absolutely no substitutes to replace human bloo...

Read More

Volunteers play an important role in today’s hospitals. They help the hos...

Read More

Rajiv Gandhi Cancer Institute and Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.

Sir Chotu Ram Marg, Sector - 5, Rohini Industrial Area, Rohini, New Delhi - 110085, India | +91-11-47022222
OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday)
Emergency Services: 24x7 All weekdays

Squadron Leader Mahendra Kumar Jain Marg, Block K, Niti Bagh, New Delhi - 110049 | +91-11-45822222
OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday)
Emergency Services: 24x7 All Weekdays

Subscribe Today For Our Healthy Tips Newsletter